Marquette Asset Management’s Clorox CLX Stock Holding History

Marquette Asset Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3	Closed	–	–	261
2022 Q2	$0	Buy	+3	New	+$429	﹤0.01%	313

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marquette Asset Management's CLX Position: Q3 2022 in Review

Marquette Asset Management sold out of Clorox (CLX) in Q3 2022, closing a stake of 3 shares.

Marquette Asset Management first reported a position in CLX in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 1,045 funds tracked by Wall St. Rank hold CLX as of Q3 2022.

Marquette Asset Management reported no remaining Clorox position as of Q3 2022 after selling out during the quarter.
Marquette Asset Management sold 3 Clorox shares in Q3 2022.
Marquette Asset Management first reported a position in Clorox in Q2 2022 and held it in 1 quarter.
Marquette Asset Management's Clorox position peaked at $0 in Q2 2022.
1,045 funds tracked by Wall St. Rank held Clorox as of Q3 2022.

Based on Marquette Asset Management's 13F filing for Q3 2022, filed 6 Oct 2022.